THERAPY WITH HUMAN RECOMBINANT ERYTHROPOIETIN IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
Open Access
- 1 August 1992
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 81 (4), 628-630
- https://doi.org/10.1111/j.1365-2141.1992.tb03014.x
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trial [see comments]Blood, 1992
- Pharmacologic doses of recombinant human erythropoietin in the treatment of myelodysplastic syndromes [see comments]Blood, 1991
- The treatment of anaemia in the myelodysplastic syndromes with recombinant human erythropoietinBritish Journal of Haematology, 1991